12 Einträge gefunden

1. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma:a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

   1. Franklin, Cindy
   2. Mohr, Peter
   3. Bluhm, Leonie
   4. Meier, Friedegund
   5. Garzarolli, Marlene
   6. Weichenthal, Michael
   7. Kähler, Katharina

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

   1. Zaremba, Anne
   2. Mohr, Peter
   3. Gutzmer, Ralf
   4. Meier, Friedegund
   5. Pföhler, Claudia
   6. Weichenthal, Michael
   7. Terheyden, Patrick

   2023 - Forschungsinformationssystem des UKE
3. Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma

   1. Ammann, Nadine L
   2. Schwietzer, Yasmin F
   3. Mess, Christian
   4. Stadler, Julia-Christina
   5. Geidel, Glenn
   6. Kött, Julian
   7. Pantel, Klaus

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study

   1. Gebhardt, Christoffer
   2. Simon, Sonja C S
   3. Weber, Rebekka
   4. Gries, Mirko
   5. Mun, Dong Hun
   6. Reinhard, Raphael
   7. Holland-Letz, Tim

   2021 - Forschungsinformationssystem des UKE
5. Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis

   1. Jäger, Katharina
   2. Larribère, Lionel
   3. Wu, Huizi
   4. Weiss, Christel
   5. Gebhardt, Christoffer
   6. Utikal, Jochen

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
6. Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy

   1. Haselmann, Verena
   2. Gebhardt, Christoffer
   3. Brechtel, Ingrid
   4. Duda, Angelika
   5. Czerwinski, Claudia
   6. Sucker, Antje
   7. Holland-Letz, Tim

   2018 - Forschungsinformationssystem des UKE
7. Willingness to pay for a cure of low-risk melanoma patients in Germany

   1. Augustin, Matthias
   2. Blome, Christine
   3. Forschner, Andrea
   4. Gutzmer, Ralf
   5. Hauschild, Axel
   6. Heinzerling, Lucie
   7. Livingstone, Elisabeth

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
8. The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

   1. Kähler, Katharina
   2. Blome, Christine
   3. Forschner, A
   4. Gutzmer, Ralf
   5. Hauschild, Axel
   6. Heinzerling, L
   7. Livingstone, Elisabeth

   2018 - Forschungsinformationssystem des UKE
9. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas

   1. Baum, Cornelia
   2. Weiss, Christel
   3. Gebhardt, Christoffer
   4. Utikal, Jochen
   5. Marx, Alexander
   6. Koenen, Wolfgang
   7. Géraud, Cyrill

   2017 - Forschungsinformationssystem des UKE
10. Myeloid-derived suppressor cells and tumor escape from immune surveillance

    1. Umansky, Viktor
    2. Blattner, Carolin
    3. Fleming, Viktor
    4. Hu, Xiaoying
    5. Gebhardt, Christoffer
    6. Altevogt, Peter
    7. Utikal, Jochen

    2017 - Forschungsinformationssystem des UKE
11. The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation

    1. Dollt, Claudia
    2. Becker, Kathrin
    3. Michel, Julia
    4. Melchers, Susanne
    5. Weis, Cleo-Aron
    6. Schledzewski, Kai
    7. Krewer, Andreas

    2017 - Forschungsinformationssystem des UKE
12. D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress

    1. Desch, Anna
    2. Gebhardt, Christoffer
    3. Utikal, Jochen
    4. Schneider, Stefan W

    2017 - Forschungsinformationssystem des UKE